Novartis AG announced it will acquire Avidity Biosciences Inc. (NASDAQ: RNA) for $12 billion in cash, strengthening its neuroscience pipeline ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE